{"product_id":"harvard-update-on-severe-asthma-2025","title":"Harvard Update on Severe Asthma 2025","description":"\u003ch3\u003eHarvard Update on Severe Asthma 2025\u003c\/h3\u003e\n\u003cstrong\u003e Include: 29 videos + 30 pdfs, size: 6 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: pulmonologists, allergists, primary care physician\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAssessment and management of severe asthma are issues currently at the forefront of modern asthma investigation and care. This two-day, live, hybrid (in person and online) course will provide insights from a multidisciplinary team representing the \u003cem\u003eSevere Asthma Program\u003c\/em\u003e at Brigham and Women’s Hospital and the Mass General Brigham Asthma Center. Our focus will include both pediatric and adult patients with asthma. We will devote one day to assessment of severe asthma and complicating illnesses and one day to its treatment, including novel approaches to management. Lectures will cover topics in the immunology and genetics of severe asthma, aspirin-exacerbated respiratory disease, eosinophilic lung diseases including allergic bronchopulmonary aspergillosis, occupational asthma, obesity and asthma, and special considerations in school-age children. Presentations on the contribution of gastroesophageal reflux disease, upper airway obstruction, and sinusitis\/nasal polyposis will be given by a gastroenterologist, voice specialist, and otolaryngologist, respectively. We will focus on the treatment of asthma, including recent GINA and NAEPP Guidelines, modern biologics, and novel therapies in development. We will review in depth our protocol for the evaluation of severe asthma and have opportunity to discuss interesting cases of severe asthma. This course is appropriate for allergists, pulmonologists, and other specialists with an interest in the management of severe asthma.\u003cbr\u003e\u003ch3 class=\"variant-1\"\u003eWho Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSpecialty Physicians\u003c\/li\u003e\n\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\n\u003cli\u003eNurse Practitioners\u003c\/li\u003e\n\u003cli\u003ePhysician Assistants\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"variant-1\"\u003eLearning Objectives\u003c\/h3\u003e\u003cbr\u003eUpon completion of this activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSystematically evaluate difficult-to-control asthma.\u003c\/li\u003e\n\u003cli\u003eIdentify specific severe asthma phenotypes\/endotypes.\u003c\/li\u003e\n\u003cli\u003eUtilize novel asthma therapeutics with confidence.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eThe \u003cstrong\u003eHarvard Update on Severe Asthma 2025\u003c\/strong\u003e course is designed for healthcare professionals specializing in \u003cstrong\u003easthma management and respiratory medicine\u003c\/strong\u003e. The target audience includes:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulmonologists\u003c\/strong\u003e and \u003cstrong\u003eallergists\u003c\/strong\u003e treating severe asthma.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrimary care physicians\u003c\/strong\u003e managing asthma patients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNurse practitioners\u003c\/strong\u003e and \u003cstrong\u003ephysician assistants\u003c\/strong\u003e working in respiratory care.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical trainees\u003c\/strong\u003e seeking advanced education in asthma treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResearchers\u003c\/strong\u003e focused on asthma pathophysiology and novel therapies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eThis course provides \u003cstrong\u003estate-of-the-art updates\u003c\/strong\u003e on \u003cstrong\u003ediagnostic assessment, treatment strategies, and emerging research\u003c\/strong\u003e in severe asthma.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch2 data-end=\"149\" data-start=\"129\"\u003eProgram \u0026amp; Updates\u003c\/h2\u003e\n\u003cul data-end=\"268\" data-start=\"150\"\u003e\n\u003cli data-end=\"201\" data-start=\"150\"\u003e\n\u003cp data-end=\"201\" data-start=\"152\"\u003eWelcome \u0026amp; Introduction to the Online Audience\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"268\" data-start=\"202\"\u003e\n\u003cp data-end=\"268\" data-start=\"204\"\u003eUpdate on Severe Asthma 2025 — Key Changes \u0026amp; Takeaways (PDF)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"301\" data-start=\"270\"\u003eDisease Biology \u0026amp; Phenotypes\u003c\/h2\u003e\n\u003cul data-end=\"601\" data-start=\"302\"\u003e\n\u003cli data-end=\"360\" data-start=\"302\"\u003e\n\u003cp data-end=\"360\" data-start=\"304\"\u003eAsthma Genetics and the Environment in Severe Asthma\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"417\" data-start=\"361\"\u003e\n\u003cp data-end=\"417\" data-start=\"363\"\u003eMolecular Sub-Phenotypes in Asthma — Guest Lecture\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"477\" data-start=\"418\"\u003e\n\u003cp data-end=\"477\" data-start=\"420\"\u003eEosinophilic Lung Disease and Its Overlap with Asthma\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"539\" data-start=\"478\"\u003e\n\u003cp data-end=\"539\" data-start=\"480\"\u003eInsights from the Severe Asthma Research Program (SARP)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"601\" data-start=\"540\"\u003e\n\u003cp data-end=\"601\" data-start=\"542\"\u003ePathophysiologic Insights from Novel Imaging Techniques\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"628\" data-start=\"603\"\u003eDiagnosis \u0026amp; Assessment\u003c\/h2\u003e\n\u003cul data-end=\"967\" data-start=\"629\"\u003e\n\u003cli data-end=\"695\" data-start=\"629\"\u003e\n\u003cp data-end=\"695\" data-start=\"631\"\u003eDiagnostic Assessment of Severe Asthma — Practical Framework\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"758\" data-start=\"696\"\u003e\n\u003cp data-end=\"758\" data-start=\"698\"\u003eDiagnostic Considerations in Children with Severe Asthma\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"806\" data-start=\"759\"\u003e\n\u003cp data-end=\"806\" data-start=\"761\"\u003eDrivers of Asthma in School-Aged Children\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"879\" data-start=\"807\"\u003e\n\u003cp data-end=\"879\" data-start=\"809\"\u003eAirway Oscillometry in Adults and Very Young Children (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"967\" data-start=\"880\"\u003e\n\u003cp data-end=\"967\" data-start=\"882\"\u003eNew Recommendations for Interpreting Pulmonary Function Tests (PFTs) (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1005\" data-start=\"969\"\u003eEnvironment, Triggers \u0026amp; Exposures\u003c\/h2\u003e\n\u003cul data-end=\"1272\" data-start=\"1006\"\u003e\n\u003cli data-end=\"1056\" data-start=\"1006\"\u003e\n\u003cp data-end=\"1056\" data-start=\"1008\"\u003eIndoor Environments and Asthma Exacerbations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1116\" data-start=\"1057\"\u003e\n\u003cp data-end=\"1116\" data-start=\"1059\"\u003eOccupational Exposures and Severe Asthma (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1207\" data-start=\"1117\"\u003e\n\u003cp data-end=\"1207\" data-start=\"1119\"\u003eWhat Distinguishes Asthmatic vs Non-Asthmatic Allergic Airway Responses (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1272\" data-start=\"1208\"\u003e\n\u003cp data-end=\"1272\" data-start=\"1210\"\u003eThe Microbiome and Asthma — Emerging Evidence (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1299\" data-start=\"1274\"\u003eComorbidities \u0026amp; Mimics\u003c\/h2\u003e\n\u003cul data-end=\"1632\" data-start=\"1300\"\u003e\n\u003cli data-end=\"1360\" data-start=\"1300\"\u003e\n\u003cp data-end=\"1360\" data-start=\"1302\"\u003eGastroesophageal Reflux and Severe Asthma (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1434\" data-start=\"1361\"\u003e\n\u003cp data-end=\"1434\" data-start=\"1363\"\u003eLaryngeal Disordered Breathing Mimicking Severe Asthma (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1497\" data-start=\"1435\"\u003e\n\u003cp data-end=\"1497\" data-start=\"1437\"\u003eTreating Rhinosinusitis and Nasal Polyposis (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1564\" data-start=\"1498\"\u003e\n\u003cp data-end=\"1564\" data-start=\"1500\"\u003eObesity, Diabetes, and Asthma — Metabolic Links (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1632\" data-start=\"1565\"\u003e\n\u003cp data-end=\"1632\" data-start=\"1567\"\u003eAsthma Mimics to Consider: Tracheobronchomalacia (Study Hall)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1676\" data-start=\"1634\"\u003eSpecial Populations \u0026amp; Overlap Syndromes\u003c\/h2\u003e\n\u003cul data-end=\"1801\" data-start=\"1677\"\u003e\n\u003cli data-end=\"1733\" data-start=\"1677\"\u003e\n\u003cp data-end=\"1733\" data-start=\"1679\"\u003eManaging Severe Asthma in Children — Guest Lecture\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1801\" data-start=\"1734\"\u003e\n\u003cp data-end=\"1801\" data-start=\"1736\"\u003eCigarette Smoking, COPD, and Chronic Obstructive Asthma (ACO)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"1826\" data-start=\"1803\"\u003eTreatment Strategies\u003c\/h2\u003e\n\u003cul data-end=\"2129\" data-start=\"1827\"\u003e\n\u003cli data-end=\"1879\" data-start=\"1827\"\u003e\n\u003cp data-end=\"1879\" data-start=\"1829\"\u003eChoosing Among the Biologics for Severe Asthma\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1953\" data-start=\"1880\"\u003e\n\u003cp data-end=\"1953\" data-start=\"1882\"\u003eManaging Asthma with Aspirin-Exacerbated Respiratory Disease (AERD)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2007\" data-start=\"1954\"\u003e\n\u003cp data-end=\"2007\" data-start=\"1956\"\u003eAnti-Inflammatory Rescue — Options \u0026amp; Challenges\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2082\" data-start=\"2008\"\u003e\n\u003cp data-end=\"2082\" data-start=\"2010\"\u003eClinical Remission in Asthma as a Goal of Guideline-Directed Therapy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2129\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2129\" data-start=\"2085\"\u003eNovel Therapies — A Look into the Future\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-end=\"2154\" data-start=\"2131\"\u003eInteractive Learning\u003c\/h2\u003e\n\u003cul data-end=\"2283\" data-start=\"2155\"\u003e\n\u003cli data-end=\"2216\" data-start=\"2155\"\u003e\n\u003cp data-end=\"2216\" data-start=\"2157\"\u003eInteractive Case Discussions — Real-World Severe Asthma\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2283\" data-start=\"2217\"\u003e\n\u003cp data-end=\"2283\" data-start=\"2219\"\u003eCase Discussions — Complex Diagnostic \u0026amp; Therapeutic Dilemmas\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954499457122,"sku":"MED-AMB04700","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/5987638140015332107_119.jpg?v=1779378159","url":"https:\/\/meducourse.com\/products\/harvard-update-on-severe-asthma-2025","provider":"Meducourse","version":"1.0","type":"link"}